223 related articles for article (PubMed ID: 26564936)
1. A Case Report: Consecutive Cranial Neuropathies Following the Use of Phosphodiesterase-5 Inhibitors.
van Landingham SW; Singman EL
Am Orthopt J; 2015; 65():109-14. PubMed ID: 26564936
[TBL] [Abstract][Full Text] [Related]
2. Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis.
Hsu JC; Tang DH; Lu CY
Int J Clin Pract; 2015 Apr; 69(4):436-43. PubMed ID: 25311239
[TBL] [Abstract][Full Text] [Related]
3. [Current role of sildenafil in the management of erectile dysfunction].
Akhvlediani ND; Matyukhov IP
Urologiia; 2018 May; (2):142-146. PubMed ID: 29901310
[TBL] [Abstract][Full Text] [Related]
4. PDE-5 inhibitors: clinical points.
Doumas M; Lazaridis A; Katsiki N; Athyros V
Curr Drug Targets; 2015; 16(5):420-6. PubMed ID: 25392015
[TBL] [Abstract][Full Text] [Related]
5. [Phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: past, present and future].
Gamidov SI; Ovchinnikov RI; Popova AY; Izhbaev SK
Urologiia; 2017 Apr; (1):103-107. PubMed ID: 28394532
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis.
Gong B; Ma M; Xie W; Yang X; Huang Y; Sun T; Luo Y; Huang J
Int Urol Nephrol; 2017 Oct; 49(10):1731-1740. PubMed ID: 28741090
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial investigating treatment choice in Chinese men receiving sildenafil citrate and tadalafil for treating erectile dysfunction.
Bai WJ; Li HJ; Jin JJ; Xu WP; Sebastian S; Wang XF
Asian J Androl; 2017; 19(4):500-504. PubMed ID: 27101805
[TBL] [Abstract][Full Text] [Related]
8. Association of Transient Colorblindness With Sildenafil and Tadalafil.
Rosen SM; Kaja S; De Alba F
JAMA Ophthalmol; 2019 Jan; 137(1):117-118. PubMed ID: 30286227
[No Abstract] [Full Text] [Related]
9. Melanoma, Viagra, and PDE5 Inhibitors: Proliferation and Metastasis.
Houslay MD
Trends Cancer; 2016 Apr; 2(4):163-165. PubMed ID: 28741569
[TBL] [Abstract][Full Text] [Related]
10. Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.
Magee AG; Makhecha S; Bentley S
Expert Opin Drug Saf; 2015 May; 14(5):633-42. PubMed ID: 25746065
[TBL] [Abstract][Full Text] [Related]
11. Use of phosphodiesterase type 5 inhibitors in assistive living and home care settings.
Iannino-Renz R; Mager D
Appl Nurs Res; 2015 Aug; 28(3):251-3. PubMed ID: 26060141
[TBL] [Abstract][Full Text] [Related]
12. [Erectile dysfunction, PDE5A inhibitors and melanoma].
Schmutz JL
Ann Dermatol Venereol; 2015 Dec; 142(12):800-1. PubMed ID: 26293983
[No Abstract] [Full Text] [Related]
13. Fourth Cranial Nerve Palsy Associated With Sildenafil Citrate.
Lee Y; Park KA; Oh SY; Min JH; Kim BJ
J Neuroophthalmol; 2021 Mar; 41(1):e79-e80. PubMed ID: 32235216
[No Abstract] [Full Text] [Related]
14. Useful Implications of Low-dose Long-term Use of PDE-5 Inhibitors.
Mostafa T
Sex Med Rev; 2016 Jul; 4(3):270-284. PubMed ID: 27871960
[TBL] [Abstract][Full Text] [Related]
15. Major adverse cardiovascular events related to phosphodiesterase 5 inhibitors: analysis of real-life data from Eudra-Vigilance database.
DE Nunzio C; Nacchia A; Grimaldi MC; Turchi B; Rovesti L; Franco A; Guarnotta G; Voglino O; Mancini E; Baldassarri V; Lombardo R; Cicione A; Tubaro A
Minerva Urol Nephrol; 2024 Apr; 76(2):203-209. PubMed ID: 38498298
[TBL] [Abstract][Full Text] [Related]
16. [Non-arteritic anterior ischemic optic neuropathy associated with erectile dysfunction medications].
Krashin-Bichler I; Dotan G
Harefuah; 2013 Feb; 152(2):84-7, 123. PubMed ID: 23513498
[TBL] [Abstract][Full Text] [Related]
17. A Case of Recurrent Lobar Intracerebral Hemorrhage in the Setting of Phosphodiesterase-5 Inhibitor Use.
Lucchese SA; Dhaliwal AS; Kaur A; Qi L
Mo Med; 2019; 116(5):400-403. PubMed ID: 31645793
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of regular and on-demand regimen of PED5-Is in the treatment of ED after nerve-sparing radical prostatectomy for Prostate Cancer.
Qiu S; Tang Z; Deng L; Liu L; Han P; Yang L; Wei Q
Sci Rep; 2016 Sep; 6():32853. PubMed ID: 27611008
[TBL] [Abstract][Full Text] [Related]
19. Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature.
Azzouni F; Abu samra K
J Sex Med; 2011 Oct; 8(10):2894-903. PubMed ID: 21771280
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the therapeutic effects and side effects of tadalafil and sildenafil after surgery in young infants with pulmonary arterial hypertension due to systemic-to-pulmonary shunts.
Sabri MR; Bigdelian H; Hosseinzadeh M; Ahmadi A; Ghaderian M; Shoja M
Cardiol Young; 2017 Nov; 27(9):1686-1693. PubMed ID: 28994364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]